Molecular Targets for Improvement of Parkinson's Disease Therapy
|Tiziana Cocco1 and Sergio Papa1,2*|
|1Department of Basic Medical Sciences, Neurosciences and Sense Organs, University ‘A. Moro’, Bari, Italy|
|2Institute of Biomembranes and Bioenergetics, Italian National Research Council (CNR), Via G. Amendola 165/A, Bari, Italy|
|Corresponding Author :||Sergio Papa
Department of Basic Medical Sciences
Neurosciences and Sense Organs.
University ‘A. Moro’, Bari, Italy
Tel: +39 080 5448541
E-mail: [email protected]
|Received May 22, 2015; Accepted July 01, 2015; Published July 08, 2015|
|Citation: Cocco T, Papa S (2015) Molecular Targets for Improvement of Parkinson’s Disease Therapy. Brain Disord Ther 4:173. doi:10.4172/2168-975X.1000173|
|Copyright: © 2015 Cocco T, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.|
|Related article at Pubmed, Scholar Google|
This paper is a concise overview of molecular targets whose attack can contribute to improve the therapy of Parkinson’s disease. Particular attention is given to the merits of gene therapy and to the information that can be acquired, studying the hereditary forms of PD, on the pathogenetic mechanisms of Parkinsonism and putative targets for new therapeutical measures.